Baxter Internationalvs.ResMed
BAX vs RMD · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices — from surgery and cardiology to robotics.
ResMed is about 2.5× larger than Baxter International by market cap; year to date, Baxter International leads (+18.4% vs −15.4%).
Side by side
| BAX | RMD | |
|---|---|---|
| Market cap | $11.7B | $29.8B |
| Price | $22.62 | $203.87 |
| Today | +0.7% | −2.2% |
| Return YTD | +18.4% | −15.4% |
| Return 1Y | −23.8% | −21.0% |
| P/E | — | 19.6 |
| P/S | 1.0 | 5.4 |
| P/B | 1.9 | 4.6 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
Baxter InternationalBAX
Hospital products across infusion, renal care and surgery.
Full BAX profile →More comparisons in Medtech & devices
See where BAX and RMD sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →